NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹21 Cr | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -48.68 | |
| Mar2025 | ₹41 Cr | 101.67 | |
| Mar2024 | ₹20 Cr | -59.05 | |
| Mar2023 | ₹50 Cr | -11.91 | |
| Mar2022 | ₹57 Cr | - | |
Compare Consolidated Net Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,722.3 Cr | 4.3% | -8.8% | 90.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 4.3% |
-8.8% |
90.7% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses